In summary, we have shown that the biophysical features of different mutations affecting the second arginine of the NaV1.4 VSD-I S4 helix cannot fully explain why the carrier of a R222Q mutation presents with predominant myotonia while carriers of R222W and R222G present with HypoPP. This evidence concerns the gene SCN4A and hypokalemic periodic paralysis.